Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025
Filed with SSE · · 2 pages · Chinese
Release
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Notice on Convening the 2024 Annual General Meeting
- Announcement on Adjusting 2024 Annual Profit Distribution Plan
- Announcement on Attending 2024 SSE STAR Market Biological Products and CXO Industry Collective Performance Briefing
- Announcement on Changing Enterprise Type
- Announcement on Self-Inspection Report on Purchase and Sale of Shares by Relevant Subjects Related to This Transaction
Later from CABIO Biotech (Wuhan)
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Convening the Q1 2025 Performance Briefing
- Announcement on Reply to the Review Inquiry Letter of Application for Purchasing Assets and Raising Supporting Funds by Issuing Shares and Paying Cash as well as Related Party Transactions
- Announcement on Adjusting the Upper Limit of Phase II Share Repurchase Price after Implementation of Dividend Distribution for 2024
- Announcement on Plan of Shareholding Reduction by Shareholder
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)